Man Group
XBIT icon

Man Group’s XBiotech XBIT Stock Holding History

Man Group’s Portfolio XBIT Stock Details XBIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-10,611
Closed -$54.5K – 2239
2024
Q2 		$54.5K Buy
+10,611
New +$81.8K ﹤0.01% 1983
2024
Q1 		– Sell
-58,355
Closed -$233K – 2298
2023
Q4 		$233K Buy
+58,355
New +$232K ﹤0.01% 1883
2023
Q3 		– Sell
-51,292
Closed -$257K – 1733
2023
Q2 		$305K Buy
+51,292
New +$231K ﹤0.01% 1719
2023
Q1 		– Sell
-49,013
Closed -$183K – 1835
2022
Q4 		$172K Buy
49,013
+31,713
+183% +$108K ﹤0.01% 1803
2022
Q3 		$63K Buy
+17,300
New +$81.4K ﹤0.01% 1880

Other funds holding XBIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Man Group's XBIT Position: Q3 2024 in Review

Man Group sold out of XBiotech (XBIT) in Q3 2024, closing a stake of 10,611 shares — an estimated $54.5K sold.

Man Group first reported a position in XBIT in Q3 2022 and held it in 5 quarters. The position peaked at $305K in Q2 2023. 50 funds tracked by Wall St. Rank hold XBIT as of Q3 2024.

  • Man Group reported no remaining XBiotech position as of Q3 2024 after selling out during the quarter.
  • Man Group sold 10,611 XBiotech shares in Q3 2024, an estimated $54.5K.
  • Man Group first reported a position in XBiotech in Q3 2022 and held it in 5 quarters.
  • Man Group's XBiotech position peaked at $305K in Q2 2023.
  • 50 funds tracked by Wall St. Rank held XBiotech as of Q3 2024.

Based on Man Group's 13F filing for Q3 2024, filed 14 Nov 2024.